Genetic variation of the dihydrofolate reductase gene in Plasmodium vivax in Snoul, northeastern Cambodia

Acta Tropica

Volumn 92, Issue 1, 2004, Pages 1-6

  De Pécoulas, Philippe Eldin ^a   Tahar, Rachida ^b   Yi, Poravuth ^c   Thai, Khieng Heng ^c   Basco, Leonardo K ^d  

^a UNIVERSITÉ DE CAEN   (France)

^b INSTITUT PASTEUR   (France)

^c Natl Ctr Parasitol Entomol M   (Cambodia)

^d Laboratoire de Recherche sur le Paludisme Yaounde   (Cameroon)

Author keywords

Antifolate drugs; Chloroquine; Drug resistance; Malaria; Plasmodium falciparum

Indexed keywords

AMINO ACID; ARGININE; ASPARAGINE; CYSTEINE; DIHYDROFOLATE REDUCTASE; MUTANT PROTEIN; PYRIMETHAMINE; SERINE;

GENETIC VARIATION;

AMINO ACID SUBSTITUTION; ARTICLE; CAMBODIA; CODON; DNA POLYMORPHISM; GENE MUTATION; GENETIC VARIABILITY; MICROBIAL DIVERSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; SOUTHEAST ASIA; TANDEM REPEAT; WILD TYPE;

ANIMALS; ANTIMALARIALS; CAMBODIA; DRUG RESISTANCE, MICROBIAL; HUMANS; MALARIA, VIVAX; MUTATION; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; PYRIMETHAMINE; TETRAHYDROFOLATE DEHYDROGENASE; VARIATION (GENETICS);

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 3843086062     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2004.03.011     Document Type: Article

References (25)

1. Basco L.K., Eldin de Pécoulas P., Le Bras J., Wilson C.M. Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp. Parasitol. 82:1996;97-103
2. Basco L.K., Eldin de Pécoulas P., Wilson C.M., Le Bras J., Mazabraud A. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. 69:1995;135-138
3. Basco L.K., Le Bras J. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine, and artemisinin derivatives. Ann. Trop. Med. Parasitol. 88:1994;137-144
4. Cowman, A.F., 1997. The mechanisms of drug action and resistance in malaria, in: Hayes, J.D., Wolf C.R. (Eds.), Molecular Genetics of Drug Resistance. Harwood Academic Publishers, Amsterdam, The Netherlands, pp. 221-246.
5. Darlow B., Vrbova H., Gibney S., Jolley D., Stace J., Alpers M. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. II. Plasmodium vivax. Am. J. Trop. Med. Hyg. 31:1982;10-13
6. Doberstyn E.B., Teerakiartkamjorn C., Andre R.G., Phintuyothin P., Noeypatimanondh S. Treatment of vivax malaria with sulfadoxine-pyrimethamine and with pyrimethamine alone. Trans. R. Soc. Trop. Med. Hyg. 73:1979;15-17
7. Eldin de Pécoulas P., Basco L.K., Tahar R., Ouatas T., Mazabraud A. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene. 211:1998a;177-185
8. Eldin de Pécoulas P., Tahar R., Ouatas T., Mazabraud A., Basco L.K. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol. Biochem. Parasitol. 92:1998b;265-273
9. Giboda M., Denis M.B. Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro. J. Trop. Med. Hyg. 91:1988;205-211
10. Harinasuta T., Suntharasamai P., Viravan C. Chloroquine-resistant falciparum malaria in Thailand. Lancet. 2:1965;657-660
11. Imwong M., Pukrittakayamee S., Looareesuwan S., Pasvol G., Poirriez J., White N.J., Snounou G. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45:2001;3122-3127
12. Imwong M., Pukrittakayamee S., Renia L., Letourneur F., Charlieu J.P., Leartsakulpanich U., Looareesuwan S., White N.J., Snounou G. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob. Agents Chemother. 47:2003;1514-1521
13. Kidson C., Singhasivanon P., Supavej S. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian J. Trop. Med. Public Health. 30(Suppl 4):1999;1-101
14. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A.G., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:2002;380-388
15. Leartsakulpanich U., Imwong M., Pukrittayakamee S., White N.J., Snounou G., Sirawaraporn W., Yuthavong Y. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol. Biochem. Parasitol. 119:2002;63-73
16. Looareesuwan S., Olliaro P., White N.J., Chongsuphajaisiddhi T., Sabcharoen A., Thimasarn K., Nosten F., Singhasivanon P., Supavej S., Khusmith S., Wylings S., Kanyok T., Walsh D., Leggat P.A., Doberstyn E.B. Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian J. Trop. Med. Public Health. 29:1998;355-360
17. Maberti S. Desarrollo de resistencia a la pirimetamina. Presentacion de 15 casos estudiados en Trujillo, Venezuela. Archivos Venezolanos de Medicina Tropical y Parasitologia Medica. 3:1960;239-259
18. Mehlotra R.K., Fujioka H., Roepe P.D., Janneh O., Ursos L.M.B., Jacobs-Lorena V., McNamara D.T., Bockarie M.J., Kazura J.W., Kyle D.E., Fidock D.A., Zimmerman P.A. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA. 98:2001;12689-12694
19. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:2001;97-106
20. Peters, W., 1987. Chemotherapy and Drug Resistance in Malaria, second ed. Academic Press, London.
21. Ponnampalan J.T., Frank H.A. Treatment of vivax malaria with a single dose of sulphadoxine and pyrimethamine (Fansidar). Singapore Med. J. 24:1983;104-108
22. Pukrittayakamee S., Chantra A., Simpson J.A., Vanijanonta S., Clemens R., Looareesuwan S., White N.J. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44:2000;1680-1685
23. Tahar R., Eldin de Pécoulas P., Mazabraud A., Basco L.K. Plasmodium vivax: rapid detection by polymerase chain reaction and restriction fragment length polymorphism of the key mutation in dihydrofolate reductase-thymidylate synthase gene associated with pyrimethamine resistance. Exp. Parasitol. 89:1998;343-346
24. Tahar R., Eldin de Pecoulas P., Basco L.K., Chiadmi M., Mazabraud A. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Mol. Biochem. Parasitol. 113:2001;241-249
25. Thimasarn K., Sirichaisinthop J., Vijaykadja S. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/ pyrimethamine (MSP) treatment among gem miners returning from Cambodia. Southeast Asian J. Trop. Med. Public Health. 26:1995;204-212